These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 31771126)

  • 21. Novel Electrophilic and Photoaffinity Covalent Probes for Mapping the Cannabinoid 1 Receptor Allosteric Site(s).
    Kulkarni PM; Kulkarni AR; Korde A; Tichkule RB; Laprairie RB; Denovan-Wright EM; Zhou H; Janero DR; Zvonok N; Makriyannis A; Cascio MG; Pertwee RG; Thakur GA
    J Med Chem; 2016 Jan; 59(1):44-60. PubMed ID: 26529344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders.
    Galaj E; Xi ZX
    CNS Drugs; 2019 Oct; 33(10):1001-1030. PubMed ID: 31549358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple Binding Sites Contribute to the Mechanism of Mixed Agonistic and Positive Allosteric Modulators of the Cannabinoid CB1 Receptor.
    Saleh N; Hucke O; Kramer G; Schmidt E; Montel F; Lipinski R; Ferger B; Clark T; Hildebrand PW; Tautermann CS
    Angew Chem Int Ed Engl; 2018 Mar; 57(10):2580-2585. PubMed ID: 29314474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel analogs of PSNCBAM-1 as allosteric modulators of cannabinoid CB1 receptor.
    Bertini S; Chicca A; Gado F; Arena C; Nieri D; Digiacomo M; Saccomanni G; Zhao P; Abood ME; Macchia M; Gertsch J; Manera C
    Bioorg Med Chem; 2017 Dec; 25(24):6427-6434. PubMed ID: 29079014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allosteric Modulation: An Alternate Approach Targeting the Cannabinoid CB1 Receptor.
    Nguyen T; Li JX; Thomas BF; Wiley JL; Kenakin TP; Zhang Y
    Med Res Rev; 2017 May; 37(3):441-474. PubMed ID: 27879006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Negative allosteric modulators of cannabinoid receptor 2: protein modeling, binding site identification and molecular dynamics simulations in the presence of an orthosteric agonist.
    Pandey P; Roy KK; Doerksen RJ
    J Biomol Struct Dyn; 2020 Jan; 38(1):32-47. PubMed ID: 30652534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabidiol binding and negative allosteric modulation at the cannabinoid type 1 receptor in the presence of delta-9-tetrahydrocannabinol: An In Silico study.
    Chung H; Fierro A; Pessoa-Mahana CD
    PLoS One; 2019; 14(7):e0220025. PubMed ID: 31335889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological selection of cannabinoid receptor effectors: Signalling, allosteric modulation and bias.
    Manning JJ; Green HM; Glass M; Finlay DB
    Neuropharmacology; 2021 Aug; 193():108611. PubMed ID: 34000272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positive Allosteric Modulation of CB1 and CB2 Cannabinoid Receptors Enhances the Neuroprotective Activity of a Dual CB1R/CB2R Orthosteric Agonist.
    Polini B; Cervetto C; Carpi S; Pelassa S; Gado F; Ferrisi R; Bertini S; Nieri P; Marcoli M; Manera C
    Life (Basel); 2020 Dec; 10(12):. PubMed ID: 33302569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allosteric Modulators of the CB
    Morales P; Goya P; Jagerovic N; Hernandez-Folgado L
    Cannabis Cannabinoid Res; 2016; 1(1):22-30. PubMed ID: 28861476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-based identification of a G protein-biased allosteric modulator of cannabinoid receptor CB1.
    Shen S; Wu C; Lin G; Yang X; Zhou Y; Zhao C; Miao Z; Tian X; Wang K; Yang Z; Liu Z; Guo N; Li Y; Xia A; Zhou P; Liu J; Yan W; Ke B; Yang S; Shao Z
    Proc Natl Acad Sci U S A; 2024 Jun; 121(24):e2321532121. PubMed ID: 38830102
    [No Abstract]   [Full Text] [Related]  

  • 32. Enantiomer-specific positive allosteric modulation of CB
    Mitjavila J; Yin D; Kulkarni PM; Zanato C; Thakur GA; Ross R; Greig I; Mackie K; Straiker A
    Pharmacol Res; 2018 Mar; 129():475-481. PubMed ID: 29158048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis and in vitro evaluation of novel uni- and bivalent ligands for the cannabinoid receptor type 1 with variation of spacer length and structure.
    Huang G; Pemp D; Stadtmüller P; Nimczick M; Heilmann J; Decker M
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4209-14. PubMed ID: 25096297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New perspectives on the role of the neurosteroid pregnenolone as an endogenous regulator of type-1 cannabinoid receptor (CB1R) activity and function.
    Raux PL; Drutel G; Revest JM; Vallée M
    J Neuroendocrinol; 2022 Feb; 34(2):e13034. PubMed ID: 34486765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in the Understanding of the Cannabinoid Receptor 1 - Focusing on the Inverse Agonists Interactions.
    Russo S; De Azevedo WF
    Curr Med Chem; 2019; 26(10):1908-1919. PubMed ID: 29667549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PSNCBAM-1 analogs: Structural evolutions and allosteric properties at cannabinoid CB1 receptor.
    Meini S; Gado F; Stevenson LA; Digiacomo M; Saba A; Codini S; Macchia M; Pertwee RG; Bertini S; Manera C
    Eur J Med Chem; 2020 Oct; 203():112606. PubMed ID: 32682199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of novel mouse and rat CB1R isoforms and in silico modeling of human CB1R for peripheral cannabinoid therapeutics.
    Liu QR; Huang NS; Qu H; O'Connell JF; Gonzalez-Mariscal I; Santa-Cruz-Calvo S; Doyle ME; Xi ZX; Wang Y; Onaivi ES; Egan JM
    Acta Pharmacol Sin; 2019 Mar; 40(3):387-397. PubMed ID: 30202012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In silico mapping of allosteric ligand binding sites in type-1 cannabinoid receptor.
    Sabatucci A; Tortolani D; Dainese E; Maccarrone M
    Biotechnol Appl Biochem; 2018 Jan; 65(1):21-28. PubMed ID: 28833445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CB
    Mielnik CA; Lam VM; Ross RA
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110163. PubMed ID: 33152384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New approaches in the design and development of cannabinoid receptor ligands: multifunctional and bivalent compounds.
    Nimczick M; Decker M
    ChemMedChem; 2015 May; 10(5):773-86. PubMed ID: 25820617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.